Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

JS Capital Management



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
The average size of a deal this fund participated in
Portfolio companies 5
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 2

Areas of investment

  • Biotechnology
  • FinTech
  • Payments
  • Financial Services
  • Finance

Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Paidy. Among the most successful fund investment fields, there are Payments, Financial Services.

Deals in the range of more than 100 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2019.

The typical case for the fund is to invest in rounds with 4 participants. Despite the JS Capital Management, startups are often financed by Visa, Sumitomo Mitsui Trust Bank, Sumitomo Mitsui Banking Corporation. The meaningful sponsors for the fund in investment in the same round are Venrock, Tybourne Capital Management, Soros Capital Management.

The overall number of key employees were 2.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of JS Capital Management:
Typical Co-investors
JS Capital Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after JS Capital Management:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Advenio Capital Management Connecticut, Greenwich, United States
Applebee's California, Glendale, United States
BDC County Dublin, Dublin, Ireland
Bestseller Group -
ClearArc Capital Cincinnati, Ohio, United States
Constant Capital Accra, Ghana, Greater Accra
Danfeng Venture Capital China, Shanghai
Energia Hiroshima, Hiroshima Prefecture, Japan
Grand Prix Capital Australia, Bondi, New South Wales
HU Investments Montclair, New Jersey, United States
New Medical Technologies -
Renjing Yatang Cultural Communication Beijing, Beijing, China
Ripple California, San Francisco, United States
Senmed Medical Ventures -
Shanghai Boyong Asset Management China, Shanghai
The Global Emerging Markets Group New York, New York, United States
The Motley Fool Alexandria, United States, Virginia
Xinhua Huijin Beijing, Beijing, China
Zhang Shi Touzi China, Zhejiang, Zhuji

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Element Biosciences

Information Technology
$276M29 Jun 2021 San Diego, California, United States


Financial Services
$83M01 Nov 2019 Chiba Prefecture
Element Biosciences Raises $276M in Series C Financing

– Element Biosciences from San Diego develops DNA sequencing platform.
– The company closed a $276m Series C financing.
– Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price and existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock.
– The new investment will be used to scale commercial organization in anticipation of the launch of its next-generation sequencing solution.

Paidy Raises US$120 Million in Series D Round

– Paidy Inc. (Japan) has raised US$120m in Series D funding round.
– The round was led by JS Capital Management LLC, Soros Capital Management LLC, Tybourne Capital Management Ltd., and Wellington Management.
– Since late 2020, Paidy has additionally completed the loan facilities set up by upsizing the warehouse facility with Goldman Sachs, newly establishing the secured loan facility with Sumitomo Mitsui Banking Corporation and the other warehouse facility through the syndication led by Mizuho Bank, Ltd.
– This capital increase and additional debt financing from the financial institutions bring total capital raising since the company’s founding to US$585m (of which, equity is US$337m, one of the largest amounts of funding ever raised by a startup in Japan).


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent JS Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 167M
Peak activity year 2021
Lead investments 0
Follow on index 0.29
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Element Biosciences

Information Technology
$276M29 Jun 2021 San Diego, California, United States


Financial Services
$83M01 Nov 2019 Chiba Prefecture
Crunchbase icon

Content report

The following text will be sent to our editors: